Upload Image (Max 20MB per Image)
KU Leuven and FIT Biotech have reached a global license and partnership agreement for the development of novel immunotherapeutics leveraging FIT Biotech's gene transport unit (GTU) technology for transient in vivo expression of monoclonal ...
Tags: KU Leuven, Novel Immunotherapeutics